D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 84 Citations 33,938 432 World Ranking 9848 National Ranking 5212

Research.com Recognitions

Awards & Achievements

Member of the Association of American Physicians

Overview

What is she best known for?

The fields of study she is best known for:

  • Cancer
  • Internal medicine
  • Radiation therapy

The scientist’s investigation covers issues in Radiation therapy, Immunotherapy, Immunology, Immune system and Cancer research. Her studies deal with areas such as Cancer and Abscopal effect as well as Radiation therapy. She combines subjects such as Radiation oncology, Oncology and Antigen with her study of Abscopal effect.

The study incorporates disciplines such as T cell, CD8 and Transplantation in addition to Immunotherapy. Her Tumor microenvironment, Inflammation and Immunosurveillance study in the realm of Immunology connects with subjects such as Barnesiella intestinihominis. Her research in Immune system intersects with topics in Cancer cell and Ovarian cancer.

Her most cited work include:

  • Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota (1345 citations)
  • Fractionated but not single dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody (931 citations)
  • Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated (793 citations)

What are the main themes of her work throughout her whole career to date?

Silvia C. Formenti mainly focuses on Radiation therapy, Breast cancer, Internal medicine, Cancer research and Oncology. Her biological study spans a wide range of topics, including Cancer, Abscopal effect, Immunotherapy and Clinical trial. Her Immunotherapy research integrates issues from T cell and Blockade.

As a member of one scientific family, Silvia C. Formenti mostly works in the field of Breast cancer, focusing on Prone position and, on occasion, Supine position. Silvia C. Formenti performs integrative study on Cancer research and Ionizing radiation. Her Oncology study typically links adjacent topics like Combined Modality Therapy.

She most often published in these fields:

  • Radiation therapy (43.85%)
  • Breast cancer (27.61%)
  • Internal medicine (26.68%)

What were the highlights of her more recent work (between 2016-2021)?

  • Radiation therapy (43.85%)
  • Internal medicine (26.68%)
  • Cancer research (22.97%)

In recent papers she was focusing on the following fields of study:

Silvia C. Formenti mainly investigates Radiation therapy, Internal medicine, Cancer research, Immunotherapy and Immune system. Her Radiation therapy research is multidisciplinary, relying on both Cancer, Medical physics, Immunology and Clinical trial. Her Internal medicine research incorporates themes from Gastroenterology and Oncology.

Her Cancer research research includes themes of Cancer cell, T cell, Interferon, CD8 and Breast cancer. The various areas that Silvia C. Formenti examines in her Immunotherapy study include Tumor microenvironment, Radiosurgery and Blockade. Her Immune system research includes elements of Adjuvant, Receptor, Cytokine and Effector.

Between 2016 and 2021, her most popular works were:

  • DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity. (573 citations)
  • Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial (438 citations)
  • Using immunotherapy to boost the abscopal effect (333 citations)

In her most recent research, the most cited papers focused on:

  • Cancer
  • Internal medicine
  • Radiation therapy

Radiation therapy, Cancer research, Immune system, Immune checkpoint and Abscopal effect are her primary areas of study. Her Radiation therapy research incorporates elements of Tumor microenvironment, Cancer, Immunotherapy and Immunology. Silvia C. Formenti has included themes like Cancer cell and Interferon in her Cancer research study.

Her study in Immune system is interdisciplinary in nature, drawing from both Context, Breast cancer, Stereotactic radiation therapy and Abemaciclib. Silvia C. Formenti focuses mostly in the field of Abscopal effect, narrowing it down to matters related to Blockade and, in some cases, Cytotoxic T cell, CTLA-4 and T cell. Her work in Internal medicine addresses subjects such as Oncology, which are connected to disciplines such as Combined Modality Therapy and Stage.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

Marie Vétizou;Marie Vétizou;Marie Vétizou;Jonathan M. Pitt;Jonathan M. Pitt;Jonathan M. Pitt;Romain Daillère;Romain Daillère;Romain Daillère;Patricia Lepage.
Science (2015)

2313 Citations

Fractionated but not single dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody

M. Zahidunnabi Dewan;Ashley E. Galloway;Noriko Kawashima;J. Keith Dewyngaert.
Clinical Cancer Research (2009)

1346 Citations

Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated

Sandra Demaria;Bruce Ng;Mary Louise Devitt;James S Babb.
International Journal of Radiation Oncology Biology Physics (2004)

1152 Citations

Postmastectomy Radiotherapy: Clinical Practice Guidelines of the American Society of Clinical Oncology*

Abram Recht;Stephen B. Edge;Lawrence J. Solin;David S. Robinson.
Journal of Clinical Oncology (2001)

1121 Citations

DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity.

Claire Vanpouille-Box;Amandine Alard;Amandine Alard;Molykutty J. Aryankalayil;Yasmeen Sarfraz.
Nature Communications (2017)

986 Citations

Translational control in cancer.

Deborah Silvera;Silvia C. Formenti;Robert J. Schneider.
Nature Reviews Cancer (2010)

982 Citations

Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer.

Sandra Demaria;Noriko Kawashima;Anne Marie Yang;Mary Louise Devitt.
Clinical Cancer Research (2005)

936 Citations

Systemic effects of local radiotherapy

Silvia C Formenti;Sandra Demaria.
Lancet Oncology (2009)

905 Citations

Combining Radiotherapy and Cancer Immunotherapy: A Paradigm Shift

Silvia C. Formenti;Sandra Demaria.
Journal of the National Cancer Institute (2013)

890 Citations

Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial

Narek Shaverdian;Aaron E Lisberg;Krikor Bornazyan;Darlene Veruttipong.
Lancet Oncology (2017)

768 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Silvia C. Formenti

Guido Kroemer

Guido Kroemer

Sorbonne University

Publications: 160

Lorenzo Galluzzi

Lorenzo Galluzzi

Cornell University

Publications: 140

Laurence Zitvogel

Laurence Zitvogel

University of Paris-Saclay

Publications: 82

Jedd D. Wolchok

Jedd D. Wolchok

Cornell University

Publications: 69

Oliver Kepp

Oliver Kepp

Institut Gustave Roussy

Publications: 54

Thomas A. Buchholz

Thomas A. Buchholz

The University of Texas MD Anderson Cancer Center

Publications: 44

Benjamin Frey

Benjamin Frey

University of Erlangen-Nuremberg

Publications: 41

Udo S. Gaipl

Udo S. Gaipl

University of Erlangen-Nuremberg

Publications: 40

Frank A. Vicini

Frank A. Vicini

Beaumont Health

Publications: 40

Bruce G. Haffty

Bruce G. Haffty

Rutgers, The State University of New Jersey

Publications: 40

Ralph R. Weichselbaum

Ralph R. Weichselbaum

University of Chicago

Publications: 38

Jennifer A. Wargo

Jennifer A. Wargo

The University of Texas MD Anderson Cancer Center

Publications: 37

Charles G. Drake

Charles G. Drake

Columbia University

Publications: 35

Michael A. Postow

Michael A. Postow

Memorial Sloan Kettering Cancer Center

Publications: 34

Radek Spisek

Radek Spisek

Sotio (Czechia)

Publications: 33

Roberto Orecchia

Roberto Orecchia

European Institute of Oncology

Publications: 32

Trending Scientists

Paul Xirouchakis

Paul Xirouchakis

University of Strathclyde

Richard O'Kennedy

Richard O'Kennedy

Dublin City University

Chao Jin

Chao Jin

Soochow University

Brenda J. Andrews

Brenda J. Andrews

University of Toronto

Duanqing Pei

Duanqing Pei

Guangzhou Institutes of Biomedicine and Health

Guoyi Zhou

Guoyi Zhou

Nanjing University of Information Science and Technology

Paul D. Thomas

Paul D. Thomas

University of Southern California

Bernard Guiard

Bernard Guiard

Centre national de la recherche scientifique, CNRS

Kapil Mehta

Kapil Mehta

MolQ Laboratory

Walter Luyten

Walter Luyten

KU Leuven

Mardge H. Cohen

Mardge H. Cohen

Rush University

Michael E. Jenkin

Michael E. Jenkin

University of Bristol

James N. Huckins

James N. Huckins

United States Geological Survey

Dingbao Wang

Dingbao Wang

University of Central Florida

Yi-Yuan Tang

Yi-Yuan Tang

Arizona State University

E. Antonio Chiocca

E. Antonio Chiocca

Brigham and Women's Hospital

Something went wrong. Please try again later.